Kobayashi, Erena
Kanno, Shigenori
Kawakami, Nobuko
Narita, Wataru
Saito, Makoto
Endo, Keiko
Iwasaki, Masaki
Kawaguchi, Tomohiro
Yamada, Shigeki
Ishii, Kazunari
Kazui, Hiroaki
Miyajima, Masakazu
Ishikawa, Masatsune
Mori, Etsuro
Tominaga, Teiji
Tanaka, Fumiaki
Suzuki, Kyoko
Funding for this research was provided by:
JSPS KAKENHI (JP16K01447, JP20K11202)
Health Labour Sciences Research (20GB1002, 20GC1008)
Article History
Received: 12 January 2022
Accepted: 8 August 2022
First Online: 17 August 2022
Competing interests
: E.K., S.K., N.K., W.N., M.S., K.E., M.I., and T.K. have no competing interests to disclose. S.Y. received grants from the G-7 Scholarship Foundation, Taiju Life Social Welfare Foundation, and FUJIFILM Corporation and speaker honoraria from Fujifilm Medical Systems, Integra Japan, and Daiichi Sankyo, outside the submitted work. K.I. received funding for speaker honoraria from Nihon Medi-Physics. H.K. received funding for travel and/or speaker honoraria from Integra Japan, Nihon Medi-Physics, Ono Pharmaceutical, Pfizer, Eisai, Daiichi-Sankyo, Janssen Pharmaceutical, Takeda Pharmaceutical, Novartis Pharma and Medtronic Inc. and receives research support from MSD KK, Daiichi-Sankyo, Eisai, a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research, a Health Labour Sciences Research Grant, and the Japan Agency for Medical Research and Development. M.M. received funding for travel and/or speaker honoraria from Integra Japan, Nihon Medi-Physics, Medtronic, Novartis Pharma, Eisai and Daiichi-Sankyo. M.I. received speaker honoraria from Integra Japan, Nihon Medi-Physics, Medtronic and Eisai. E.M. received speaker honoraria from Eisai, Daiichi-Sankyo, Novartis Pharma, Integra Japan, Nihon Medi-Physics, Janssen Pharmaceutical, Medtronic, Otsuka, Tanabe-Mitsubishi, Ono, and Fujifilm Medical; served as a consultant for Lundbeck; and received research support from Eisai, Daiichi-Sankyo, Novartis Pharma, Tanabe-Mitsubishi, Fujifilm Medical, and the Ministry of Health, Labour and Welfare Japan. T.T., F.T., and K.S. have no competing interests to disclose.